Hartmut Kroll

3.4k total citations
49 papers, 2.5k citations indexed

About

Hartmut Kroll is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Hartmut Kroll has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 17 papers in Genetics and 15 papers in Surgery. Recurrent topics in Hartmut Kroll's work include Platelet Disorders and Treatments (33 papers), Blood groups and transfusion (30 papers) and Blood disorders and treatments (16 papers). Hartmut Kroll is often cited by papers focused on Platelet Disorders and Treatments (33 papers), Blood groups and transfusion (30 papers) and Blood disorders and treatments (16 papers). Hartmut Kroll collaborates with scholars based in Germany, United States and United Kingdom. Hartmut Kroll's co-authors include Sentot Santoso, V. Kiefel, Ulrich J. Sachs, C. Mueller‐Eckhardt, Andreas Greinacher, G. Mueller‐Eckhardt, Petra Eichler, Sabine Schmidt, Theodore E. Warkentin and Andreas Ruf and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Blood.

In The Last Decade

Hartmut Kroll

48 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hartmut Kroll Germany 25 1.6k 629 628 369 342 49 2.5k
Paul Friese United States 22 1.4k 0.8× 169 0.3× 177 0.3× 770 2.1× 136 0.4× 35 2.6k
Sylvia Bellucci France 22 1.4k 0.9× 142 0.2× 159 0.3× 158 0.4× 180 0.5× 80 2.1k
Robert Roubey United States 29 1.2k 0.7× 380 0.6× 249 0.4× 1.3k 3.5× 323 0.9× 62 3.4k
MC Berndt Australia 20 942 0.6× 252 0.4× 430 0.7× 301 0.8× 329 1.0× 35 1.7k
TS Zimmerman United States 29 3.4k 2.1× 602 1.0× 555 0.9× 650 1.8× 108 0.3× 52 3.9k
Yoshiyuki Kurata Japan 26 1.3k 0.8× 208 0.3× 329 0.5× 322 0.9× 245 0.7× 90 2.2k
Lucia Catani Italy 29 1.3k 0.8× 117 0.2× 275 0.4× 397 1.1× 71 0.2× 109 2.5k
Samuel A. Burstein United States 23 1.4k 0.8× 113 0.2× 140 0.2× 326 0.9× 79 0.2× 37 2.1k
John Freedman Canada 20 850 0.5× 177 0.3× 410 0.7× 248 0.7× 68 0.2× 48 1.8k
LA Harker United States 19 979 0.6× 76 0.1× 368 0.6× 163 0.4× 113 0.3× 28 1.8k

Countries citing papers authored by Hartmut Kroll

Since Specialization
Citations

This map shows the geographic impact of Hartmut Kroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Kroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Kroll more than expected).

Fields of papers citing papers by Hartmut Kroll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hartmut Kroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Kroll. The network helps show where Hartmut Kroll may publish in the future.

Co-authorship network of co-authors of Hartmut Kroll

This figure shows the co-authorship network connecting the top 25 collaborators of Hartmut Kroll. A scholar is included among the top collaborators of Hartmut Kroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hartmut Kroll. Hartmut Kroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Julien, et al.. (2025). SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade. Frontiers in Immunology. 16. 1654374–1654374.
2.
Schindewolf, Marc, Hartmut Kroll, Andreas Recke, et al.. (2013). High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy. Journal of Allergy and Clinical Immunology. 132(1). 131–139. 30 indexed citations
3.
4.
Schindewolf, Marc, Hartmut Kroll, İngo Marzi, et al.. (2011). Application, tolerance and safety of fondaparinux therapy in a German hospital: A prospective single-centre experience. Thrombosis Research. 129(1). 17–21. 10 indexed citations
5.
Markart, Philipp, Robert D. Nass, Clemens Ruppert, et al.. (2010). Safety and Tolerability of Inhaled Heparin in Idiopathic Pulmonary Fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(3). 161–172. 43 indexed citations
6.
Schindewolf, Marc, Hartmut Kroll, Jūratė Garbaravičienė, et al.. (2010). Low Allergenic Potential With Fondaparinux: Results of a Prospective Investigation. Mayo Clinic Proceedings. 85(10). 913–919. 23 indexed citations
7.
Andrei‐Selmer, Cornelia, et al.. (2009). Low‐avidity HPA‐1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion. 49(5). 943–952. 25 indexed citations
8.
Nguyen, Xuan Duc, Brigitte K. Flesch, Ulrich J. Sachs, et al.. (2009). IMMUNOHEMATOLOGY: Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test. Transfusion. 49(12). 2700–2708. 27 indexed citations
9.
Santoso, Sentot, et al.. (2007). Heterogeneity of HPA‐3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes. Transfusion. 48(3). 463–472. 28 indexed citations
10.
Kroll, Hartmut, et al.. (2006). Heterogeneity of Platelet Alloantigens and Alloantibodies: New Insights into Structure and Function. Transfusion Medicine and Hemotherapy. 33(3). 244–253. 7 indexed citations
11.
Castro, Vagner, Hartmut Kroll, Sérgio Tadeu Martins Marba, et al.. (2006). A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns. Transfusion. 47(1). 59–66. 14 indexed citations
12.
Morel‐Kopp, Marie‐Christine, Jeannine M. Clemetson, Kenneth J. Clemetson, et al.. (2005). A common ancestral glycoprotein (GP) 9 1828A>G (Asn45Ser) gene mutation occurring in European families from Australia and Northern Europe with Bernard-Soulier syndrome (BSS). Thrombosis and Haemostasis. 94(9). 599–605. 13 indexed citations
13.
Kroll, Hartmut, et al.. (2005). Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. Thrombosis and Haemostasis. 94(7). 132–135. 287 indexed citations
14.
15.
Kroll, Hartmut, et al.. (2005). Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a. Thrombosis and Haemostasis. 94(12). 1224–1229. 27 indexed citations
16.
Sachs, Ulrich J., et al.. (2003). Bernard–Soulier syndrome due to the homozygous Asn‐45Ser mutation in GPIX: an unexpected, frequent finding in Germany. British Journal of Haematology. 123(1). 127–131. 26 indexed citations
17.
Santoso, Sentot, Ulrich J. Sachs, Hartmut Kroll, et al.. (2002). The Junctional Adhesion Molecule 3 (JAM-3) on Human Platelets is a Counterreceptor for the Leukocyte Integrin Mac-1. The Journal of Experimental Medicine. 196(5). 679–691. 333 indexed citations
18.
Kroll, Hartmut, et al.. (1996). Diclofenac‐induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug‐dependent antibodies. British Journal of Haematology. 95(4). 640–644. 40 indexed citations
19.
Bald, R., V. Kiefel, Hartmut Kroll, et al.. (1996). THERAPY WITH INTRAVENOUS IMMUNOGLOBULIN G (ivIgG) DURING PREGNANCY FOR FETAL ALLOIMMUNE (HPA-1a(Zwa)) THROMBOCYTOPENIC PURPURA. Prenatal Diagnosis. 16(6). 495–502. 13 indexed citations
20.
Mueller‐Eckhardt, C., V. Kiefel, Hartmut Kroll, & G. Mueller‐Eckhardt. (1989). HLA‐DRw6, a New Immune Response Marker for Immunization against the Platelet Alloantigen Bra. Vox Sanguinis. 57(1). 90–91. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Friese Breakdown of academic impact, for papers by Sylvia Bellucci Breakdown of academic impact, for papers by Robert Roubey Breakdown of academic impact, for papers by MC Berndt Breakdown of academic impact, for papers by TS Zimmerman Breakdown of academic impact, for papers by Yoshiyuki Kurata Breakdown of academic impact, for papers by Lucia Catani Breakdown of academic impact, for papers by Samuel A. Burstein Breakdown of academic impact, for papers by John Freedman Breakdown of academic impact, for papers by LA Harker
Rankless by CCL
2026